Table 2.
Adjusted Hazard Ratio (95% Confidence Interval) |
||||
---|---|---|---|---|
Time-varying exposure comparison | 2013–2014 | 2014–2015 | 2015–2016 | 2013–2016 Combined |
Influenza | ||||
14-day post-vaccination vs. unvaccinateda | 0.74 (0.1, 5.48) | Estimate unreliable | 1.49 (0.19, 12.03) | 0.63 (0.16, 2.60) |
14-day post-vaccination vs. vaccinatedb | 0.79 (0.1, 6.29) | Estimate unreliable | 2.26 (0.25, 20.82) | 0.66 (0.16, 2.84) |
Vaccinatedb vs. unvaccinateda | 0.94 (0.46, 1.93) | 1.34 (0.59, 3.01) | 0.66 (0.26, 1.69) | 0.96 (0.6, 1.52) |
Non-influenza respiratory pathogen | ||||
14-day post-vaccination vs. unvaccinateda | 1.03 (0.49, 2.21) | 1.94 (1.08, 3.48) | 2.09 (1.12, 3.88) | 1.65 (1.14, 2.38) |
14-day post-vaccination vs. vaccinatedb | 0.53 (0.24, 1.14) | 1.72 (0.91, 3.27) | 1.66 (0.85, 3.23) | 1.13 (0.77, 1.68) |
Vaccinatedb vs. unvaccinateda | 1.97 (1.39, 2.8) | 1.12 (0.78, 1.62) | 1.26 (0.86, 1.87) | 1.44 (1.17, 1.77) |
Symptoms without pathogen detected | ||||
2-day post-vaccination vs. unvaccinateda | 1.8 (0.24, 13.51) | 2.44 (0.6, 10.02) | 0.17 (0.01, 32.41) | 1.3 (0.42, 4.08) |
2-day post-vaccination vs. vaccinatedb | 0.82 (0.1, 7.43) | 1.56 (0.38, 6.47) | 0.13 (0.01, 48.53) | 1.03 (0.33, 3.24) |
Vaccinatedb vs. unvaccinateda | 1.23 (0.79, 1.92) | 1.56 (1.12, 2.17) | 1.02 (0.71, 1.48) | 1.27 (1.02, 1.59) |
All models adjusted for age, gender, chronic respiratory condition, and autumn, winter, spring season.
Statistically significant estimates are in bold text.
Unvaccinated exposure status includes individuals prior to vaccination and those who did not receive the vaccine.
Vaccinated exposure status includes individuals after the relevant post-vaccination risk period (14-day or 2-day depending on the model).